CCI penalises investment manager of Goldman Sachs AIF for failing to notify Biocon deal
The Competition Commission of India fined Goldman Sachs AIMPL Rs 40 lakh for not notifying it about a deal that included acquiring optionally convertible debentures in Biocon Biologics, providing significant rights beyond those of ordinary shareholders, which necessitated prior notification under the Competition Act.
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
The Competition Commission of India fined Goldman Sachs AIMPL Rs 40 lakh for not notifying it about a deal that included acquiring optionally convertible debentures in Biocon Biologics, providing significant rights beyond those of ordinary shareholders, which necessitated prior notification under the Competition Act. 
